• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Clinical significance of hepatitis B virus (HBV)-DNA monitoring to detect HBV reactivation after systemic chemotherapy.

作者信息

Kusumoto Shigeru, Tanaka Yasuhito, Mizokami Masashi, Ueda Ryuzo

出版信息

J Clin Oncol. 2011 Feb 1;29(4):e100; author reply e101. doi: 10.1200/JCO.2010.33.0332. Epub 2010 Dec 20.

DOI:10.1200/JCO.2010.33.0332
PMID:21172888
Abstract
摘要

相似文献

1
Clinical significance of hepatitis B virus (HBV)-DNA monitoring to detect HBV reactivation after systemic chemotherapy.乙肝病毒（HBV）-DNA监测在检测全身化疗后HBV再激活中的临床意义。
J Clin Oncol. 2011 Feb 1;29(4):e100; author reply e101. doi: 10.1200/JCO.2010.33.0332. Epub 2010 Dec 20.
2
Surveillance and treatment protocols to detect and treat hepatitis B virus reactivation in hepatitis B surface antigen-negative/antibody to hepatitis B core antigen-positive patients receiving chemotherapy for onco-hematologic malignancies.用于检测和治疗接受肿瘤血液系统恶性肿瘤化疗的乙肝表面抗原阴性/乙肝核心抗体阳性患者中乙肝病毒再激活的监测和治疗方案。
J Clin Oncol. 2011 Mar 10;29(8):e210; author reply e211. doi: 10.1200/JCO.2010.33.6016. Epub 2011 Jan 10.
3
Fatal reactivation of hepatitis B virus in a patient who was hepatitis B surface antigen negative and core antibody positive before receiving chemotherapy for non-Hodgkin lymphoma.一名非霍奇金淋巴瘤患者在接受化疗前乙肝表面抗原阴性且核心抗体阳性，出现致命性乙肝病毒再激活。
J Clin Gastroenterol. 2009 May-Jun;43(5):496-8. doi: 10.1097/MCG.0b013e3181945942.
4
Prospective analysis of hepatitis B virus reactivation in patients with diffuse large B-cell lymphoma after rituximab combination chemotherapy.利妥昔单抗联合化疗后弥漫大 B 细胞淋巴瘤患者乙型肝炎病毒再激活的前瞻性分析。
J Clin Oncol. 2010 Dec 1;28(34):5097-100. doi: 10.1200/JCO.2010.29.7531. Epub 2010 Sep 13.
5
Hepatitis B virus reactivation in B-cell lymphoma patients treated with rituximab: analysis from the Asia Lymphoma Study Group.利妥昔单抗治疗的 B 细胞淋巴瘤患者乙型肝炎病毒再激活：亚洲淋巴瘤研究组的分析。
Eur J Cancer. 2013 Nov;49(16):3486-96. doi: 10.1016/j.ejca.2013.07.006. Epub 2013 Aug 1.
6
Hepatitis B reactivation in patients receiving cytotoxic chemotherapy: diagnosis and management.接受细胞毒性化疗的患者中乙型肝炎病毒再激活：诊断与管理。
J Gastroenterol Hepatol. 2010 May;25(5):864-71. doi: 10.1111/j.1440-1746.2010.06243.x.
7
Hepatitis B virus screening before chemotherapy for lymphoma: a cost-effectiveness analysis.淋巴瘤化疗前乙型肝炎病毒筛查：成本效益分析。
J Clin Oncol. 2012 Sep 10;30(26):3167-73. doi: 10.1200/JCO.2011.40.7510. Epub 2012 Jun 18.
8
Clinical and virological factors associated with hepatitis B virus reactivation in HBsAg-negative and anti-HBc antibodies-positive patients undergoing chemotherapy and/or autologous stem cell transplantation for cancer.与癌症患者在接受化疗和/或自体干细胞移植期间 HBsAg 阴性和抗 HBc 抗体阳性的乙型肝炎病毒再激活相关的临床和病毒学因素。
J Viral Hepat. 2010 Nov;17(11):807-15. doi: 10.1111/j.1365-2893.2009.01239.x.
9
[Prevention of hepatitis B virus reactivation in B-cell lymphoma patients receiving chemotherapy with rituximab].[接受利妥昔单抗化疗的B细胞淋巴瘤患者中乙肝病毒再激活的预防]
Rinsho Ketsueki. 2010 Mar;51(3):213-5.
10
Low incidence of hepatitis B virus reactivation during chemotherapy among diffuse large B-cell lymphoma patients who are HBsAg-negative/ HBcAb-positive: a multicenter retrospective study.HBsAg 阴性/抗-HBc 阳性的弥漫性大 B 细胞淋巴瘤患者化疗期间乙型肝炎病毒再激活发生率低：一项多中心回顾性研究。
Eur J Haematol. 2010 Sep;85(3):243-50. doi: 10.1111/j.1600-0609.2010.01474.x. Epub 2010 May 20.

引用本文的文献

1
Antiviral therapy inhibited HBV-reactivation and improved long-term outcomes in patients who underwent radiofrequency ablation for HBV-related hepatocellular carcinoma.抗病毒治疗抑制 HBV 再激活，改善了接受射频消融治疗 HBV 相关肝细胞癌患者的长期预后。
World J Surg Oncol. 2023 Feb 11;21(1):42. doi: 10.1186/s12957-023-02921-1.
2
Advanced Nanotheranostics of CRISPR/Cas for Viral Hepatitis and Hepatocellular Carcinoma.CRISPR/Cas 系统的先进纳米诊疗学在病毒性肝炎和肝细胞癌中的应用
Adv Sci (Weinh). 2021 Dec;8(24):e2102051. doi: 10.1002/advs.202102051. Epub 2021 Oct 19.
3
HBV reactivation risk factors in patients with chronic HBV infection with low replicative state and resolved HBV infection undergoing hematopoietic stem cell transplantation in Korea.
韩国慢性乙型肝炎病毒（HBV）低复制状态感染者及HBV感染已康复者接受造血干细胞移植时的HBV再激活危险因素
Hepatol Int. 2017 Jan;11(1):87-95. doi: 10.1007/s12072-016-9747-0. Epub 2016 Jun 28.
4
Clinical Analysis of the HBV Infection Status of 135 Patients with Diffuse Large B Cell Lymphoma Treated with R-CHOP or CHOP/CHOP-Like Chemotherapy.135例接受R-CHOP或CHOP/类CHOP化疗的弥漫性大B细胞淋巴瘤患者的HBV感染状况临床分析
PLoS One. 2015 Jun 8;10(6):e0129064. doi: 10.1371/journal.pone.0129064. eCollection 2015.
5
Factors associated with hepatic dysfunction in hepatitis B-positive patients with postgastrectomy adenocarcinoma.乙肝阳性胃切除术后腺癌患者肝功能障碍的相关因素
Oncol Lett. 2012 Sep;4(3):471-476. doi: 10.3892/ol.2012.745. Epub 2012 Jun 8.
6
Hepatitis B virus reactivation in patients receiving cancer chemotherapy: natural history, pathogenesis, and management.接受癌症化疗患者的乙型肝炎病毒再激活：自然史、发病机制及管理
Hepatol Int. 2013 Jun;7(2):316-26. doi: 10.1007/s12072-011-9279-6. Epub 2011 Jun 14.